News

  • Alcon India introduces Unity VCS/CS for cataract and vitreoretinal surgery

    .

    The UNITY Vitreoretinal Cataract System (VCS) and UNITY Cataract System (CS) have been introduced in India, according to a recent announcement from Alcon, a leader in eye care committed to helping people see brilliantly. A standalone cataract system (CS), which will be commercially available in the upcoming months, and a combination console (VCS), which is…

  • Doctors are reporting an increase in dengue, fever, and throat infections in Delhi

    .

    Health experts warned Monday that the national capital has seen a surge in dengue, flu, and throat infections due to the unrelenting rains. Experts claim that these conditions are exacerbated by high humidity, temperature swings, and waterlogging in many places. Because of their high rate of transmission, seasonal illnesses like dengue and influenza are becoming…

  • India’s bioeconomy grows from $10 billion to $165.7 billion in just 10 years

    .

    India’s bioeconomy has grown at one of the quickest rates in the world over the last ten years, from $10 billion in 2014 to $165.7 billion in 2024. Driven by developments in biotechnology, agricultural innovation, biomanufacturing, and healthcare, the bioeconomy is progressively emerging as a pillar of India’s sustainable growth and innovation, with an ambitious…

  • Zydus Lifesciences introduces the first trivalent flu vaccination in India

    .

    Zydus Lifesciences unveiled India’s first trivalent influenza vaccination on Tuesday, in accordance with the World Health Organization’s (WHO) global guidelines. Because seasonal influenza viruses change so quickly, vaccination formulations must be updated every year. Trivalent vaccinations were therefore suggested by the WHO for use during the Northern Hemisphere (NH) influenza season of 2025–2026. For those…

  • Indian pharmaceuticals are not subject to Trump’s tariffs

    .

    Experts speculate that the pharmaceutical industry‘s exclusion from US tariffs may be due to India’s position as the world’s largest producer of generic drugs. President Donald Trump of the United States imposed an extra 25% duty on India on Wednesday, increasing the total tariff to 50%. Nevertheless, the tariffs do not apply to India’s pharmaceutical…

  • Rapid testing of antibiotic resistance using a low-cost chip-based device from IIT Madras

    .

    An inventive and reasonably priced microfluidic device created by researchers at the Indian Institute of Technology Madras (IIT Madras) can quickly identify whether bacteria are antibiotic-resistant or susceptible. One crucial technique for determining whether medicines will be effective against a particular infection is antimicrobial susceptibility testing, or AST. It assists medical professionals in selecting the…

  • GST Council’s decision to reduce the GST on cancer and essential drugs

    .

    The Indian Medical Association (IMA) called the Goods and Services Tax (GST) Council’s decision to lower the GST on a number of cancer-related and other necessary medications a “commendable step” on Monday. The IMA said in a statement that the action will help millions of patients nationwide access and afford healthcare. According to the IMA,…

  • IIT Delhi establishes a BSL3 facility to support studies on highly contagious diseases

    .

    The Indian Institute of Technology (IIT) Delhi opened a Biosafety Level 3 (BSL3) facility on Wednesday in an effort to transform biomedical and clinical diagnostics research. The new center, the first of its kind among top Indian educational institutions, will support research on class-3 pathogen diagnostic tools and treatments. The accomplishment highlights IIT Delhi’s dedication…

  • Q1 net profit for AstraZeneca Pharma India drops 4%

    .

    AstraZeneca Pharma India Limited reported a 4.12% drop in net profit for the first quarter (Q1) of FY26 on last week. The company’s earnings dropped from Rs 58.2 crore in the previous quarter (Q4 FY25) to Rs 55.8 crore. This decline occurred in spite of a robust increase in operating revenue, which increased 9.56 percent…

  • India’s pharmaceutical industry won’t lose anything due to Trump tariff: Former ICMR Chief

    .

    Dr. N.K. Ganguly, the former Director General of the ICMR, states, the Indian pharmaceutical industry, which provides 80% of the generic medications used worldwide, will not be negatively impacted by the tariffs imposed by US President Donald Trump. The comments made by the former Indian Council for Medical Research (ICMR) coincided with worries about Trump’s…


Alexa Liv

1.5M Followers

Check out our new font generatorand level up your social bios. Need more? Head over to Glyphy for all the fancy fonts and cool symbols you could ever imagine.

Categories

Tags